Popular exclusionary diets for inflammatory bowel disease: The search for a dietary culprit

Inflammatory Bowel Diseases

Volumn 20, Issue 4, 2014, Pages 732-741

  Hwang, Caroline ^a   Ross, Viveca ^b   Mahadevan, Uma ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Crohn's disease; Diet; Disaccharides; Fermentable oligosaccharides; FODMAP; Inflammatory bowel disease; Monosaccharides; Paleolithic diet; Polyunsaturated fatty acids; Specific carbohydrate diet; Ulcerative colitis

Indexed keywords

ANIMAL FAT; ASCORBIC ACID; CALCIUM; CANOLA OIL; CARBOHYDRATE; CYANOCOBALAMIN; FAT; FOLIC ACID; FRUCTOSE; GLUCOSE; GLUTEN; INTERLEUKIN 6; LACTOSE; LEUKOTRIENE B4; MARGARINE; MONOSACCHARIDE; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; POTASSIUM; PROSTAGLANDIN E2; PYRIDOXINE; RETINOL; SOYBEAN OIL; THIAMINE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D; ZINC;

ARACHIDONIC ACID METABOLISM; BACTERIAL OVERGROWTH; BEVERAGE; BREAD; CACAO; CALORIC INTAKE; CARBOHYDRATE DIET; CARBOHYDRATE INTAKE; CARBOHYDRATE RESTRICTIVE DIET; CARDIOVASCULAR DISEASE; CATERING SERVICE; CELIAC DISEASE; CELL MEMBRANE; CEREAL; CHEESE; COFFEE; DAIRY PRODUCT; DIARRHEA; DIET; DIETARY INTAKE; DIETITIAN; DISEASE ACTIVITY; DYSBIOSIS; ELEMENTAL DIET; ENTERIC FEEDING; ERYTHROCYTE MEMBRANE; FAST FOOD; FAT INTAKE; FAT MODIFIED DIET; FAT RESTRICTIVE DIET; FECES; FERMENTATION; FOOD; FRUIT; GASTROINTESTINAL TRACT; GLUTEN FREE DIET; HEALTH PROMOTION; HOSPITALIZATION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE MOTILITY; IRON INTAKE; JAPANESE; LACTOSE INTAKE; LACTOSE INTOLERANCE; LIPID COMPOSITION; LIPID DIET; LOW CARBOHYDRATE DIET; LOW FODMAP DIET; LOW LACTOSE DIET; LOW RESIDUE DIET; MACRONUTRIENT; MICELLIZATION; MICROBIOME; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUT; OAT; OMEGA 3 ENRICHED DIET; PALEOLITHIC; PALEOLITHIC DIET; PLANT SEED; POPULATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN INTAKE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REMISSION; RETROSPECTIVE STUDY; REVIEW; RICE; SEMI ELEMENTAL DIET; SEMI VEGETARIAN DIET; SMALL INTESTINE MUCOSA; SOYBEAN; TEA; VEGETABLE; VEGETARIAN; VEGETARIAN DIET; WALNUT; WATER RETENTION; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; CROHN DISEASE; DIET THERAPY; DIETARY FIBER; LOW FAT DIET; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; DIET, GLUTEN-FREE; DIET, PALEOLITHIC; DIET, VEGETARIAN; DIETARY FIBER; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; HUMANS; LACTOSE INTOLERANCE;

EID: 84898756422     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000438427.48726.b0     Document Type: Review

References (82)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.
2. Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62: 630-649.
3. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106:563-573.
4. Chapman-Kiddell CA, Davies PS, Gillen L, et al. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2010; 16:137-151.
5. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut. [published online ahead of print July 4, 2013]. doi:10.1136/gutjnl-2013-3053.
6. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013;145:970-977.
7. Dziechciarz P, Horvath A, Shamir R, et al. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther. 2007;26: 795-806.
8. Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. [published online ahead of print July 22, 2013]. doi:10.1136/gutjnl-2012-304066.
9. Triggs CM, Munday K, Hu R, et al. Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutat Res. 2010;690:123-138.
10. Hou JK, Lee D, Lewis J. Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol. [published online ahead of print October 6, 2013]. doi: 10.1016/j.cgh.2013.09.063.
11. Levenstein S, Prantera C, Luzi C, et al. Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut. 1985;26:989-993.
12. DiPalma JA, Narvaez RM. Prediction of lactose malabsorption in referral patients. Dig Dis Sci. 1988;33:303-307.
13. Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol. 1997;92:1148-1153.
14. Hwang C, Ross V, Mahadevan U. From A to Zinc: micronutrient deficiencies in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18: 1961-1981.
15. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006;106:1631-1639.
16. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 1997;65:564-567.
17. Muegge BD, Kuczynski J, Knights D, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science. 2011;332:970-974.
18. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105-108.
19. Haas SV, Haas MP. The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases. Am J Gastroenterol. 1995;23:344-360.
20. Gottschall E. Breaking the Vicious Cycle. Baltimore, Canada: The Kirkton Press; 1994.
21. Gottschall E. Breaking the vicious cycle [Internet]. 2013. Ontario (CA): Kirkton Press Ltd. Available at: http://breakingtheviciouscycle.info. Accessed August 12, 2013.
22. Suskind DL, Wahbeh G, Gregory N, et al. Nutritional therapy in pediatric Crohn's disease: the specific carbohydrate diet. J Pediatr Gastroenterol Nutr. 2013;58:87-91.
23. Olendzki B, Persuitte G, Silverstein T, et al. Specific carbohydrate diet: pilot testing a novel treatment for inflammatory bowel disease. 2011. Presented at: Clinical and Translational Science Research Retreat, University of Massachusetts, Boston MA.
24. Cox K, Burgis J. Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-2013. Available at: http://clinicaltrials.gov/ ct2/show/NCT01749813. Assessed August 20, 2013.
25. Gibson PR, Shepherd SJ. Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Alimen Pharmacol Ther. 2005;21:1399-1409.
26. Cura AJ, Carruthers A. Role of monosaccharide transport proteins in carbohydrate assimilation, metabolism, and homeostasis. Compr Physiol. 2012;2:863-914.
27. Wilkinson-Smith MK, Lam C, Hoad C, et al. MRI study of effects of FODMAP components of small-bowel water content. Gut. 2012; 61:A39.
28. Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed short-chain carbohydrates increase deliver of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874-882.
29. de Roest RH, Dobbs BR, Chapman BAM, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract. 2013;67:895-903.
30. Halmos EP, Powers VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2013; 146:1407-1408.
31. Gearry RB, Irving PM, Barrett JS, et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis. 2009;3:8-14.
32. Low FODMAP smartphone app [Internet]. 2012. Victoria (AU): Monash University. Available at: http://www.med.monash.edu/cecs/gastro/fodmap/ iphone-app.html. Accessed August 22, 2013.
33. Fasano A, Catassi C. Clinical practice: celiac disease. N Engl J Med. 2012;367:2419.
34. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106: 508-514.
35. Yang A, Chen Y, Scherl E, et al. Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis. 2005;11:528-532.
36. Tursi A, Giorgetti GM, Brandimarte G, et al. High prevalence of celiac disease among patients with Crohn's disease. Inflamm Bowel Dis. 2005;11:662-666.
37. Parmar AS, Lappalainen M, Paavola-Sakki P, et al. Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients. Genes Immun. 2012;13:474-480.
38. Festen EA, Goyette P, Green T, et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet. 2011; 7:e1001283.
39. Lettre G, Rioux JD. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet. 2008;17:R116-R121.
40. Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol. 2012;107:1898-1906.
41. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology. 2009;137:1912-1933.
42. Dunne MR, Elliott L, Hussey S, et al. Persistent changes in circulating and intestinal gd T cell subsets, invariant natural killer T cells and mucosalassociated invariant T cells in children and adults with coeliac disease. PLoS One. 2013;8:e76008.
43. Sapone A, Lammers KM, Casolaro V, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med. 2011;9:23.
44. Lammers KM, Khandelwal S, Chaudhry F, et al. Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease. Immunology. 2011;132:432-440.
45. Wagner SJ, Schmidt A, Effenberger MJ, et al. Semisynthetic diet ameliorates Crohn's disease-like ileitis in TNFDARE/WT mice through antigen-independent mechanisms of gluten. Inflamm Bowel Dis. 2013; 19:1285-1294.
46. Immunology. 2011;132(3):432-440.
47. Ding S, Chi MM, Scull BP, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 2010;5:e12191.
48. Lam YY, Ha CW, Campbell CR, et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012;7: e34233.
49. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1:6ra14.
50. Shoda R, Matsueda K, Yamato S, et al. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741-745.
51. Chiba M, Abe T, Tsuda H, et al. Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol. 2010;16:2484-2495.
52. Patterson E, Wall R, Fitzgerald GF, et al. Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab. 2012;2012:539426.
53. Marion-Letellier R, Savoye G, Beck PL, et al. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013;19:650-661.
54. Shores DR, Binion DG, Freeman BA, et al. New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis. 2010;17:2192-2204.
55. Turner D, Shah PS, Steinhart AH, et al. Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses. Inflamm Bowel Dis. 2011;17:336-345.
56. Turner D, Zlotkin SH, Shah PS, et al. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2009;CD006320.
57. Feagan BG, Sandborn WJ, Mittmann U, et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA. 2008;299:1690-1697.
58. Davis DL. Paleolithic diet, evolution, and carcinogens. Science. 1987;238: 1633-1634.
59. Jew S, AbuMweis SS, Jones PJ. Evolution of the human diet: linking our ancestral diet to modern functional foods as a means of chronic disease prevention. J Med Food. 2009;12:925-934.
60. Kuipers RS, Luxwolda MF, Dijck-Brouwer DA, et al. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. JAMA. 2008;299:1690-1697.
61. Uchiyama K, Nakamura M, Odahara S, et al. N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1696-1707.
62. Klonoff DC. The beneficial effects of a paleolithic diet on type 2 diabetes and other risk factors for cardiovascular disease. J Diabetes Sci Technol. 2009;3:1229-1232.
63. Duerksen DR, Nehra V, Bistrian BR, et al. Appropriate nutritional support in acute and complicated Crohn's disease. Nutrition. 1998;14:462-465.
64. Verma S, Brown S, Kirkwood B, et al. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol. 2000;95:735-739.
65. Dziechciarz P, Horvath A, Shamir R, et al. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther. 2007;26: 795-806.
66. Beattie RM. Enteral nutrition as primary therapy in childhood Crohn's disease: control of intestinal inflammation and anabolic response. JPEN J Parenter Enteral Nutr. 2005;29(4 suppl):S151-S155.
67. Johnson T, Macdonald S, Hill SM, et al. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut. 2006;55:356-361.
68. Grogan JL, Casson DH, Terry A, et al. Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up. Inflamm Bowel Dis. 2012;18: 246-253.
69. Fernández-Banares F, Cabré E, Esteve-Comas M, et al. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr. 1995;19:356-364.
70. Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995;108:1056-1067.
71. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007;CD000542.
72. Guo Z, Wu R, Zhu W, et al. Effect of exclusive enteral nutrition on healthrelated quality of life for adults with active Crohn's disease. Nutr Clin Pract. 2013;28:499-505.
73. Hiwatashi N. Enteral nutrition for Crohn's disease in Japan. Dis Colon Rectum. 1997;40(10 suppl):S48-S53.
74. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomizedcontrolled trial. Aliment Pharmacol Ther. 2006;24:1333-1340.
75. Hanai H, Iida T, Takeuchi K, et al. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease. Dig Liver Dis. 2012; 44:649-654.
76. Yamamoto T, Shiraki M, Nakahigashi M, et al. Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study. Int J Colorectal Dis. 2013;28:335-340.
77. Sazuka S, Katsuno T, Nakagawa T, et al. Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn's disease. Eur J Clin Nutr. 2012;66:1219-1223.
78. Levine A, Wine E. Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis. Inflamm Bowel Dis. 2013;19: 1322-1329.
79. Kajiura T, Takeda T, Sakata S, et al. Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis. Dig Dis Sci. 2009;54:1892-1900.
80. Menezes JS, Andrade MC, Senra B, et al. Immunological activities are modulated by enteral administration of an elemental diet in mice. Clin Nutr. 2006;25:643-652.
81. Swidsinski A, Ung V, Sydora BC, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis. 2009;15:359-364.
82. Roberts CL, Keita AV, Duncan SH, et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut. 2010;59:1331-1339.